98%
921
2 minutes
20
Emerging pollutants increasingly threaten aquatic ecosystems and human health. However, the risk assessment of these pollutants is constrained by insufficient toxicity data for aquatic species. In this study, a predictive framework has been established to predict the toxicity of potential pollutants across 16 aquatic species, including marine and freshwater species of varying trophic levels and to simulate their species sensitivity distributions (SSDs). Machine learning analysis indicated that per- and polyfluoroalkyl substances (PFASs) and organophosphate esters (OPEs) exhibited higher toxicity in marine species compared to freshwater species. The presence of aromatic rings and chlorine substituents was associated with increased toxicity of the OPEs, and the toxicity of alkyl OPEs showed a positive correlation with side chain length. Key parameters affecting PFAS toxicity included the chain length, substituent type, and number of ether bonds. Additionally, a comprehensive ecological risk assessment framework, integrating persistence, bioaccumulation, toxicity, and concentration, was developed to evaluate 13 PFASs and 6 OPEs in the Bohai Sea. Notably, our assessment framework identified several compounds, such as perfluorododecanoic acid, perfluoro(3,5-dioxahexanoic) acid, and tris(1-chloro-2-propyl) phosphate, previously considered as low or nonrisk, as posing significant ecological risks in this region. Thus, this framework offers a robust tool for advancing the risk assessment of emerging aquatic pollutants.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.est.4c12654 | DOI Listing |
Anal Methods
September 2025
Key Laboratory of Biorheological Science and Technology of Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, P. R. China.
Aflatoxin B1 (AFB1) is one of the most toxic mycotoxins that pose great health threats to humans. Herein, an aptasensor-based fluorescent signal amplification strategy is developed for the detection of AFB1. Initially, the AFB1 aptamers labelled with carboxyfluorescein (FAM) are adsorbed onto graphene oxide (GO), triggering energy transfer.
View Article and Find Full Text PDFJ Histotechnol
September 2025
Department of Pathology, Peking University Third Hospital, Beijing, China.
Amyloidosis encompasses a spectrum of rare disorders characterized by extracellular amyloid deposition. Achieving an accurate early diagnosis of systemic amyloidosis necessitates biopsy-specific pathological evaluation. Formalin-fixed, paraffin-embedded liver biopsy specimens were examined using Congo red staining, electron microscopy, immunohistochemistry (IHC), immunofluorescence, and Congo red-assisted laser microdissection with mass spectrometry (LMD/MS).
View Article and Find Full Text PDFStroke
September 2025
Division of Neonatology, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, the Netherlands. (B.O.v.O., M.R., M.S.S., E.L., L.S.d.V., S.J.S.).
Background: Monochorionic twins, characterized by placental sharing and vascular anastomoses, carry a high risk of brain injury, including perinatal arterial ischemic stroke (PAIS). However, the pathophysiology and timing-related risk factors of PAIS remain unclear.
Methods: Retrospective cohort of all monochorionic twins with neuroimaging-confirmed PAIS born from 2005 to 2024 and evaluated at a Dutch national referral center.
Eur J Case Rep Intern Med
August 2025
Cardiac Sciences Division, Department of Medicine, King Abdulaziz Hospital, Ministry of National Guard Health Affairs (MNGHA), Al Ahsa, Saudi Arabia.
Unlabelled: Anomalous origin of the coronary arteries is a rare congenital condition that can present as non-specific chest pain or shortness of breath or remain asymptomatic. Early identification is critical as certain variants are linked with a high risk of sudden cardiac death. Here, we report the case of a 53-year-old female with hypertension, hypothyroidism, obesity (class II) and a history of intermittent chest pain radiating to the left arm for two years.
View Article and Find Full Text PDFEur J Case Rep Intern Med
August 2025
General medicine department, Universidad de Cartagena, Cartagena, Colombia.
Background: Romosozumab is a sclerostin-inhibiting monoclonal antibody that is effective and safe for anabolic treatment in patients with osteoporosis. Its main adverse effects are local; the severity of these injection-site reactions in clinical trials was generally mild.
Case Report: We present a case of a 71-year-old Colombian woman with osteoporosis at very high risk of fractures with no relevant history of drug allergies.